Endocrinology, Vol 132, 2141-2148, Copyright © 1993 by Endocrine Society

ARTICLES

The mechanisms underlying the glucose dependence of arginine vasopressin-induced insulin secretion in beta-cells

M Lu, SP Soltoff, GC Yaney and AE Boyd 3d
Division of Endocrinology, Diabetes, Metabolism, and Molecular Medicine, New England Medical Center, Boston, Massachusetts.

The mechanisms underlying the glucose dependence of arginine vasopressin (AVP)-stimulated insulin secretion were examined in a hamster insulin-secreting cell line (HIT cells). At 1.67 mM glucose, 100 nM AVP stimulated biphasic changes in free cytosolic Ca2+ ([Ca2+]i) and insulin secretion. The initial spike of [Ca2+]i came from an intracellular pool and was accompanied by parallel changes in the levels of inositol 1,4,5-trisphosphate. The following sustained increase in [Ca2+]i was associated with membrane depolarization and Ca2+ influx through voltage-dependent Ca2+ channels. The rapid phase of insulin secretion and the [Ca2+]i spike were resistant to the Ca2+ channel blocker nimodipine, whereas the sustained insulin secretion and the protracted increase in [Ca2+]i were inhibited by nimodipine. Thus, biphasic increases in [Ca2+]i mediated the biphasic insulin secretory pattern. In the absence of glucose, 100 nM AVP triggered a transient smaller spike in [Ca2+]i, but did not stimulate membrane depolarization, Ca2+ influx, or insulin secretion. However, the increase in inositol 1,4,5-trisphosphate was similar to that seen at 1.67 mM glucose. Both the AVP-induced [Ca2+]i spike and sustained [Ca2+]i increase were augmented by glucose. We concluded that the initial AVP receptor-mediated activation of phospholipase-C is not altered by glucose, but both intracellular Ca2+ release and extracellular Ca2+ influx through voltage-dependent Ca2+ channels triggered by AVP are glucose dependent and explain the sensitivity of AVP-stimulated insulin release to this metabolite.

This article has been cited by other articles:

				Y. Fujiwara, M. Hiroyama, A. Sanbe, T. Aoyagi, J.-i. Birumachi, J. Yamauchi, G. Tsujimoto, and A. Tanoue Insulin hypersensitivity in mice lacking the V1b vasopressin receptor J. Physiol., October 1, 2007; 584(1): 235 - 244. [Abstract] [Full Text] [PDF]

				C. Schofl, J. Borger, T. Mader, M. Waring, A. von zur Muhlen, and G. Brabant Tolbutamide and diazoxide modulate phospholipase C-linked Ca2+ signaling and insulin secretion in beta -cells Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E639 - E647. [Abstract] [Full Text] [PDF]